The relationship between coronary collateral circulation and blood high-sensitivity C-reactive protein levels;Koroner kolateral dolaşim ile serum yüksek duyarlikli C-reaktif protein düzeyleri arasindaki ilişki

Turk Kardiyoloji Dernegi Arsivi

Volumn 39, Issue 1, 2011, Pages 23-28

  Kadi, Hasan ^a   Ceyhan, Köksal ^a   Karayakali, Metin ^a   Koç, Fatih ^a   Çelik, Ataç ^a   Önalan, Orhan ^a  

^a GAZIOSMANPASA UNIVERSITY   (Turkey)

Author keywords

C reactive protein; Collateral circulation; Coronary angiography; Coronary artery disease; Coronary stenosis

Indexed keywords

C REACTIVE PROTEIN;

ACUTE CORONARY SYNDROME; AGE; ANGIOCARDIOGRAPHY; ARTICLE; CLINICAL ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORONARY ARTERY COLLATERAL CIRCULATION; CORONARY ARTERY DISEASE; CORONARY ARTERY SURGERY; FEMALE; HEART INFARCTION; HUMAN; INFLAMMATORY DISEASE; LOGISTIC REGRESSION ANALYSIS; MALE; PERCUTANEOUS CORONARY INTERVENTION; PROTEIN BLOOD LEVEL; SENSITIVITY ANALYSIS; SEX DIFFERENCE;

BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CORONARY CIRCULATION; FEMALE; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS;

EID: 79959959874     PISSN: 10165169     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Levin DC. Pathways and functional significance of the coronary collateral circulation. Circulation 1974;50:831-7.
2. Elayda MA, Mathur VS, Hall RJ, Massumi GA, Garcia E, de Castro CM. Collateral circulation in coronary artery disease. Am J Cardiol 1985;55:58-60. (Pubitemid 15152522)
3. Pohl T, Seiler C, Billinger M, Herren E, Wustmann K, Mehta H, et al. Frequency distribution of collateral flow and factors influencing collateral channel development. Functional collateral channel measurement in 450 patients with coronary artery disease. J Am Coll Cardiol 2001;38:1872-8. (Pubitemid 33116557)
4. Tommasi S, Carluccio E, Bentivoglio M, Buccolieri M, Mariotti M, Politano M, et al. C-reactive protein as a marker for cardiac ischemic events in the year after a first, uncomplicated myocardial infarction. Am J Cardiol 1999;83:1595-9. (Pubitemid 29287999)
5. Toss H, Lindahl B, Siegbahn A, Wallentin L. Prognostic influence of increased fibrinogen and C-reactive protein levels in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease. Circulation 1997;96:4204-10.
6. Liuzzo G, Biasucci LM, Gallimore JR, Grillo RL, Rebuzzi AG, Pepys MB, et al. The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina. N Engl J Med 1994;331:417-24. (Pubitemid 24247397)
7. Ridker PM, Buring JE, Shih J, Matias M, Hennekens CH. Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation 1998;98:731-3. (Pubitemid 28391836)
8. Koenig W, Sund M, Fröhlich M, Fischer HG, Löwel H, Döring A, et al. C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992. Circulation 1999;99:237-42.
9. Rentrop KP, Cohen M, Blanke H, Phillips RA. Changes in collateral channel filling immediately after controlled coronary artery occlusion by an angioplasty balloon in human subjects. J Am Coll Cardiol 1985;5:587-92. (Pubitemid 15141963)
10. Piek JJ, van Liebergen RA, Koch KT, Peters RJ, David GK. Clinical, angiographic and hemodynamic predictors of recruitable collateral flow assessed during balloon angioplasty coronary occlusion. J Am Coll Cardiol 1997;29:275-82. (Pubitemid 27059955)
11. Güleç S, Özdemir AO, Maradit-Kremers H, Dinçer I, Atmaca Y, Erol C. Elevated levels of C-reactive protein are associated with impaired coronary collateral development. Eur J Clin Invest 2006;36:369-75. (Pubitemid 43742693)
12. Kerner A, Gruberg L, Goldberg A, Roguin A, Lavie P, Lavie L, et al. Relation of C-reactive protein to coronary collaterals in patients with stable angina pectoris and coronary artery disease. Am J Cardiol 2007;99:509-12. (Pubitemid 46215557)
13. Schwartz H, Leiboff RH, Bren GB, Wasserman AG, Katz RJ, Varghese PJ, et al. Temporal evolution of the human coronary collateral circulation after myocardial infarction. J Am Coll Cardiol 1984;4:1088-93. (Pubitemid 15184183)
14. Baroldi G, Scomazzoni G. Coronary circulation in the normal and the pathological heart. Washington, DC: Office of the Surgeon General, Department of the Army. 1967.
15. Ziche M, Morbidelli L, Masini E, Amerini S, Granger HJ, Maggi CA, et al. Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by substance P. J Clin Invest 1994;94:2036-44. (Pubitemid 24348244)
16. Guzman RJ, Abe K, Zarins CK. Flow-induced arterial enlargement is inhibited by suppression of nitric oxide synthase activity in vivo. Surgery 1997;122:273-9.
17. Schneeweis C, Gräfe M, Bungenstock A, Spencer-Hänsch C, Fleck E, Goetze S. Chronic CRP-exposure inhibits VEGF-induced endothelial cell migration. J Atheroscler Thromb 2010;17:203-12.
18. Fichtlscherer S, Rosenberger G, Walter DH, Breuer S, Dimmeler S, Zeiher AM. Elevated C-reactive protein levels and impaired endothelial vasoreactivity in patients with coronary artery disease. Circulation 2000;102:1000-6. (Pubitemid 30657516)
19. Verma S, Wang CH, Li SH, Dumont AS, Fedak PW, Badiwala MV, et al. A self-fulfilling prophecy: C-reactive protein attenuates nitric oxide production and inhibits angiogenesis. Circulation 2002;106:913-9. (Pubitemid 34925323)
20. Venugopal SK, Devaraj S, Yuhanna I, Shaul P, Jialal I. Demonstration that C-reactive protein decreases eNOS expression and bioactivity in human aortic endothelial cells. Circulation 2002;106:1439-41.
21. Ridker PM, Danielson E, Fonseca FA, Genest J, Gotto AM Jr, Kastelein JJ, et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med 2008;359:2195-207.
22. Zbinden S, Brunner N, Wustmann K, Billinger M, Meier B, Seiler C. Effect of statin treatment on coronary collateral flow in patients with coronary artery disease. Heart 2004;90:448-9. (Pubitemid 38406926)
23. Nishikawa H, Miura S, Zhang B, Shimomura H, Arai H, Tsuchiya Y, et al. Pravastatin promotes coronary collateral circulation in patients with coronary artery disease. Coron Artery Dis 2002;13:377-81. (Pubitemid 36106246)
24. Dinçer I, Ongun A, Turhan S, Özdol C, Kumbasar D, Erol C. Association between the dosage and duration of statin treatment with coronary collateral development. Coron Artery Dis 2006;17:561-5. (Pubitemid 44231685)
25. Aras D, Geyik B, Topaloǧlu S, Ergün K, Ayaz S, Maden O, et al. Serum level of lipoprotein (a) is inversely associated with the development of coronary collateral circulation. Coron Artery Dis 2006;17:159-63. (Pubitemid 44366273)